Awareness of the impact of cardiovascular disease on the late morbidity and
mortality in patients with Systemic Lupus Erythematosus (SLE) is increasin
g. Clinical events secondary to accelerated atherosclerosis have been docum
ented in lupus cohorts across the globe. We review the history and epidemio
logy of cardiovascular disease in patients with SLE.